Sumitomo Mitsui Trust Holdings, Inc. Guardant Health, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 88,694 shares of GH stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,694
Previous 317,694
72.08%
Holding current value
$2.22 Million
Previous $6.55 Million
60.92%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$292 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$282 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$153 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$113 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$112 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.56B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...